Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,241 to 1,260 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies. | Results Chem | 2022 | 34926138 | PubTator, text mining | PubMed |
| COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review. | 3 Biotech | 2022 | 34926119 | PubTator, text mining | PubMed |
| Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions. | Saudi J Biol Sci | 2022 | 34924802 | PubTator, text mining | PubMed |
| A structural view of the SARS-CoV-2 virus and its assembly. | Curr Opin Virol | 2022 | 34915287 | PubTator, text mining | PubMed |
| Where all the Roads Meet? A Crossover Perspective on Host Factors Regulating SARS-CoV-2 infection. | J Mol Biol | 2022 | 34914966 | PubTator, text mining | PubMed |
| SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response. | iScience | 2022 | 34901782 | PubTator, text mining | PubMed |
| Pandemic strategies with computational and structural biology against COVID-19: A retrospective. | Comput Struct Biotechnol J | 2022 | 34900126 | PubTator, text mining | PubMed |
| Emergence of a novel SARS-CoV-2 Pango lineage B.1.1.526 in West Bengal, India. | J Infect Public Health | 2022 | 34896696 | PubTator, text mining | PubMed |
| Analysis of SARS-CoV-2 mutations in the main viral protease (NSP5) and its implications on the vaccine designing strategies. | Vacunas | 2022 | 34876891 | PubTator, text mining | PubMed |
| In silico analyses of major active constituents of fingerroot (Boesenbergia rotunda) unveils inhibitory activities against SARS-CoV-2 main protease enzyme. | Saudi J Biol Sci | 2022 | 34849082 | PubTator, text mining | PubMed |
| Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021. | Infect Genet Evol | 2022 | 34848355 | PubTator, text mining | PubMed |
| Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design. | Nat Rev Mol Cell Biol | 2022 | 34824452 | PubTator, text mining | PubMed |
| Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2: A pan India study. | Virus Res | 2022 | 34822953 | PubTator, text mining | PubMed |
| Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting Mpro and Sepsis in Mice. | Inflammation | 2022 | 34822072 | PubTator, text mining | PubMed |
| Re-purposing of hepatitis C virus FDA approved direct acting antivirals as potential SARS-CoV-2 protease inhibitors. | J Mol Struct | 2022 | 34815586 | PubTator, text mining | PubMed |
| Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening. | Future Med Chem | 2022 | 34814706 | PubTator, text mining | PubMed |
| Metaviromic identification of discriminative genomic features in SARS-CoV-2 using machine learning. | Patterns (N Y) | 2022 | 34812427 | PubTator, text mining | PubMed |
| Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage. | Virus Res | 2022 | 34780883 | PubTator, text mining | PubMed |
| PDBsum extras: SARS-CoV-2 and AlphaFold models. | Protein Sci | 2022 | 34779073 | PubTator, text mining | PubMed |
| SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions. | Nucleic Acids Res | 2022 | 34761257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=63